GALENA BIOPHARMA INC | 1,967 Euro | +0,085 +4,52 % | |
| WKN: A1JLGN ISIN: US3632561086 Ticker-Symbol: RXK | Frankfurt | 22.05.13 | 08:10 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 20.05. | RXi Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference | 49 | PR Newswire | |
| WESTBOROUGH, Mass., May 20, 2013 /PRNewswire/ --RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing... Mehr lesen zu: RXi Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference | ||||
| 15.05. | RXi Pharmaceuticals Corp - 8-K, Current Report | 2 | SEC Filings | |
| 15.05. | RXi Pharmaceuticals Corp - 10-Q, Quaterly Report | 4 | SEC Filings | |
| 13.05. | Galena Biopharma: Stock First, Science Second? | 5 | Seeking Alpha | |
| 09.05. | RXi Pharmaceuticals to Present at IBC's 15th Annual TIDES: Oligonucleotide and Peptide Therapeutics Conference | 50 | PR Newswire | |
| WESTBOROUGH, Mass., May 9, 2013 /PRNewswire/ --RXi Pharmaceuticals Corporation (OTCQB: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies... Mehr lesen zu: RXi Pharmaceuticals to Present at IBC's 15th Annual TIDES: Oligonucleotide and Peptide Therapeutics Conference | ||||
| 02.05. | Galena Biopharma, Inc. - 8-K, Current Report | 10 | SEC Filings | |
| 24.04. | RXi Pharmaceuticals Corp - 8-K, Departure of Directors or Certain Officers; Election of Directors; ... | 3 | SEC Filings | |
| 23.04. | MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope | 114 | PR Newswire | |
| LONDON, April 23, 2013 /PRNewswire/ --
Following the expiration of patents on several blockbuster drugs, big pharma companies have been looking to boost their product pipeline. While in-house research... Mehr lesen zu: MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope | ||||
| 03.04. | Galena Biopharma: Will Developments Continue In 2013? | 27 | Seeking Alpha | |
| 29.03. | RXi Pharmaceuticals CEO reports 'nearly flawless' first year | 8 | bizjournals | |
| 26.03. | Galena Biopharma spinout RXi Pharma raises $26M | 7 | bizjournals | |
| 25.03. | Galena Biopharma: A Small Cap Looking For Revenues | 7 | Seeking Alpha | |
| 21.03. | RXI Pharmaceuticals, Corp. (OTC:RXII) Retreats After Two Days of Selling | 5 | HotStocked.com | |
| 20.03. | A Great Move For Galena Biopharma | 4 | Seeking Alpha | |
| 19.03. | Galena Biopharma adds cancer-pain management drug to portfolio | - | bizjournals | |
| 19.03. | Morning Research on Arena Pharma, Incyte, Galena Biopharma, and Novavax | 112 | PR Newswire | |
| LONDON, March 19, 2013 /PRNewswire/ --
One of the biggest trends to emerge in the healthcare industry in the last year has been the expiration of patents on several blockbuster drugs. The trend is... Mehr lesen zu: Morning Research on Arena Pharma, Incyte, Galena Biopharma, and Novavax | ||||
| 18.03. | Galena Biopharma Acquires Abstral Sublingual Tablets in US | - | Benzinga.com | |
| 18.03. | Orexo sells Abstral in the United States to Galena Biopharma, Inc. | 62 | Business Wire | |
| Telephone conference March 18 at 1:00pm CET
Regulatory News:
Orexo AB (STO:ORX) today announced that it sold Abstral® (fentanyl)
... Mehr lesen zu: Orexo sells Abstral in the United States to Galena Biopharma, Inc. | ||||
| 15.03. | Samsung Turns Up The Heat On Apple With New Galaxy Phone Futures Flat After S&P Closed At New High - Top Trading Stock Focus: Eastman Kodak, Fannie Mae, AMR Corp, Green Innovations, RXI Pharmaceuticals | 246 | PR Newswire | |
| LONDON, March 15, 2013 /PRNewswire/ --
Shares in Apple (AAPL) were indicating a higher open for the first time in about 2 weeks this morning in pre-market trading. Apple Inc has been under immense... Mehr lesen zu: Samsung Turns Up The Heat On Apple With New Galaxy Phone Futures Flat After S&P Closed At New High - Top Trading Stock Focus: Eastman Kodak, Fannie Mae, AMR Corp, Green Innovations, RXI Pharmaceuticals | ||||
| 14.03. | RXi Pharmaceuticals, Corp. (OTC:RXII) Continues with Steep Climb | 3 | HotStocked.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| ARENA PHARMACEUTICALS | 6,14 | +0,11 % | Arena Pharmaceuticals - Out To Launch Or Out To Lunch? |
| SUNESIS PHARMACEUTICALS | 4,299 | -3,18 % | Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 12:30 PM |
| CATALYST PHARMACEUTICAL PARTNERS | 0,722 | +5,25 % | Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill |
| CHELSEA THERAPEUTICS | 1,398 | -3,59 % | Lead Counsel in Securities Class Action Against Chelsea Therapeutics International Ltd. Announces Court Hearing |
| PHARMAUST | 0,001 | 0 % | PHARMAUST LIMITED: Appendix 3B & s708 Notice |
